Stem Cell Therapy for Autism Limited to Approved Trials
Why in the news
The Health Ministry reminded States and UTs that stem cell treatment for autism is permitted only in a clinical-trial setting.
Key facts
- Condition: Autism Spectrum Disorder (ASD).
- Direction: therapy only through duly approved clinical trials.
- Advisory date: 16 September 2026; addressed to States and UTs.
- It reiterates rules already in force.
- Background: the Supreme Court’s decision of 30 January 2026 in the case titled Yash Charitable Trust & Ors. v. Union of India & Ors.
Exam angle
- Issuing authority: Union Health Ministry.
- Therapy covered: stem cell therapy for ASD.
- Court case behind the advisory: Yash Charitable Trust v. Union of India.